IA
MDCO

IFP Advisors’s Medicines Co MDCO Stock Holding History

IFP Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-102
Closed -$3K – 4025
2018
Q3 		$3K Hold
102
– – ﹤0.01% 3488
2018
Q2 		$4K Buy
102
+97
+1,940% +$3.15K ﹤0.01% 3422
2018
Q1 		$0 Hold
5
– – ﹤0.01% 3887
2017
Q4 		$0 Sell
5
-110
-96% -$3.39K ﹤0.01% 4254
2017
Q3 		$4K Hold
115
– – ﹤0.01% 3569
2017
Q2 		$4K Hold
115
– – ﹤0.01% 3564
2017
Q1 		$6K Hold
115
– – ﹤0.01% 3239
2016
Q4 		$4K Buy
115
+37
+47% +$1.31K ﹤0.01% 3448
2016
Q3 		$3K Buy
78
+73
+1,460% +$2.75K ﹤0.01% 3510
2016
Q2 		$0 Buy
+5
New +$176 ﹤0.01% 4192
2016
Q1 		– Sell
-24
Closed -$1K – 3795
2015
Q4 		$1K Buy
+24
New +$907 ﹤0.01% 3625

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

IFP Advisors's MDCO Position: Q4 2018 in Review

IFP Advisors sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 102 shares — an estimated $3K sold.

IFP Advisors first reported a position in MDCO in Q4 2015 and held it in 11 quarters. The position peaked at $6K in Q1 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • IFP Advisors reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • IFP Advisors sold 102 Medicines Co shares in Q4 2018, an estimated $3K.
  • IFP Advisors first reported a position in Medicines Co in Q4 2015 and held it in 11 quarters.
  • IFP Advisors's Medicines Co position peaked at $6K in Q1 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on IFP Advisors's 13F filing for Q4 2018, filed 23 Jan 2019.